Abstract 4992: The occurrence of immune-related adverse events indicates better efficacy of immune checkpoint blockade in solid tumors: A systematic review and meta-analysis

作者
Xu Yang,Dongxu Wang,Jianzhen Lin,Jianping Xiong,Junyu Long,Yi Bai,Jin‐Song Bian,Hanchun Huang,Xiaobo Yang,Yilei Mao,Xinting Sang,Haitao Zhao
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:79 (13_Supplement): 4992-4992
标识
DOI:10.1158/1538-7445.am2019-4992
摘要

Abstract Introduction: Immune-related adverse events (irAEs) were mostly induced by immune checkpoint blockade (ICB) and were associated with the immune response. Whether irAEs are associated with clinical benefits during ICB treatment in cancer patients remains unclear. This systematic review and meta-analysis aimed to investigate the relationship between irAEs and clinical efficacy. Methods: We systemically searched and selected irAEs and clinical outcome data from cancer patients treated with ICB in the PubMed, Embase, and Cochrane Central Trial databases up to July 26, 2018. Keywords used for the search included PD-1, PD-L1, CTLA-4, immune checkpoint and immune-related adverse events. The relationships between the occurrence of irAEs and the objective response rate (ORR), progression-free survival (PFS) and overall survival (OS) were assessed using relative risk (RR) or hazard ratio (HR) values and 95% confidence intervals (CIs) in random-effect models. Results: Nineteen eligible observational articles were included in this systematic review and fourteen studies including 3022 participants (1264 with irAEs and 1758 with non-irAE) were included in our meta-analysis. The occurrence of irAEs was significantly associated with higher ORR (RR = 2.36, 95% CI: 1.85-3.02; P < 0.001), better PFS (HR = 0.48, 95% CI: 0.26-0.70; P < 0.001), and longer OS (HR = 0.42; 95% CI = 0.18-0.67; P = 0.001) than those in the non-irAE group. Subgroup analysis showed that the effect size of ORR in anti-PD-1 therapy (RR = 2.68, 95% CI, 2.21-3.26) was inferior to that of the anti-CTLA-4 therapy (RR = 1.91, 95% CI, 0.44-8.32). The meta-regression models also found that ICB type (anti-CTLA-4 or anti-PD-1) were associated with significant heterogeneity (P = 0.005). Conclusion: In conclusion, irAEs indicate greater ORR, PFS and OS than non-irAEs in ICB treatment, and the relationship in anti-PD-1 therapy was stronger than in anti-CTLA-4 therapy. With appropriate management of irAEs, the clinical predictor, continued treatment may be possible to maximize its potential ICB benefits. Note: This abstract was not presented at the meeting. Citation Format: Xu Yang, Dongxu Wang, Jianzhen Lin, Jianping Xiong, Junyu Long, Yi Bai, Jin Bian, Hanchun Huang, Xiaobo Yang, Yilei Mao, Xinting Sang, Haitao Zhao. The occurrence of immune-related adverse events indicates better efficacy of immune checkpoint blockade in solid tumors: A systematic review and meta-analysis [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 4992.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
余香的应助被一二三采纳,获得10
1秒前
oui发布了新的文献求助10
1秒前
图图发布了新的文献求助10
2秒前
爆米花的应助被在游的客采纳,获得10
2秒前
3秒前
3秒前
桐桐的应助被SCL987654321采纳,获得10
4秒前
4秒前
Jun的应助被zbw采纳,获得10
4秒前
4秒前
4秒前
5秒前
yee完成签到,获得积分10
5秒前
黑米粥发布了新的文献求助200
5秒前
wawawa发布了新的文献求助10
5秒前
5秒前
绝迹天明完成签到,获得积分10
5秒前
yn107发布了新的文献求助30
5秒前
虞忱发布了新的文献求助10
7秒前
桐桐的应助被个性向卉采纳,获得10
8秒前
饱满一刀发布了新的文献求助10
8秒前
Sally发布了新的文献求助10
9秒前
9秒前
9秒前
绝迹天明发布了新的文献求助30
10秒前
无极微光的应助被yee采纳,获得20
10秒前
10秒前
10秒前
yzj完成签到,获得积分10
11秒前
null的应助被江江采纳,获得10
11秒前
嘻嘻哈哈的应助被zbw采纳,获得10
11秒前
SUZHEN完成签到,获得积分10
11秒前
BING完成签到,获得积分20
11秒前
shaperly完成签到,获得积分10
11秒前
中国完成签到 ,获得积分10
12秒前
13秒前
14秒前
CWQ完成签到 ,获得积分10
14秒前
ddw发布了新的文献求助10
14秒前
西瓜皮发布了新的文献求助100
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187592
求助须知:如何正确求助?哪些是违规求助? 9575705
关于积分的说明 21842471
捐赠科研通 7785407
什么是DOI,文献DOI怎么找? 3435057
关于科研通互助平台的介绍 2559461
邀请新用户注册赠送积分活动 2481952